IMPROVEMENT OF GENE THERAPY IN PATIENTS WITH ADA-DEFICIENT SCID USING PERIPHERAL BLOOD LYMPHOCYTES, BONE MARROW AND CORD BLOOD PROGENITOR CELLS (CLINICAL RESEARCH UNIT)
- 3 Anni 2000/2003
 - 309.874€ Totale Fondi
 
Descrizione non disponibile
Pubblicazioni Scientifiche
- 1999 BIODRUGS 
Potential of gene therapy in bone marrow transplantation